NCT01370187

Montelukast for Acute Bronchiolitis and Postbronchiolitis Viral Induced Wheezing

Montelukast for Acute Bronchiolitis and Postbronchiolitis Viral Induced Wheezing in Infants 3 to 12 Months of Age in Bandar Abbas Children' Hospital

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 146 (actual)
• Sponsor: Hormozgan University of Medical Sciences · Academic / Other
• Sex: All
• Age: 3 Months – 12 Months
• Healthy volunteers: Not accepted

Summary

The aim of the current study is to evaluate the effect of Montelukast in treatment of acute bronchiolitis and postbronchiolitis viral induced wheezing of infants 3 to 12 months of age in Bandar Abbas Children' hospital.

Detailed description

All the patients will be evaluated at the baseline, during hospitalization (daily) and at 2 months and 6 months after starting the intervention.

Conditions

• Bronchiolitis
• Wheezing
• Cough

Interventions

Type	Name	Description
DRUG	Montelukast	Montelukast 4mg daily for 2 months

Timeline

• Start date: 2010-07-01
• Primary completion: 2011-04-01
• Completion: 2011-06-01
• First posted: 2011-06-09
• Last updated: 2011-06-14

Locations

1 site across 1 country: Iran